This article was originally published in The Gray Sheet
Small bone fixation system production will commence in July 2001 followed by U.S. and European launches in the fourth quarter. The firm received 510(k) clearance from FDA on June 27 for use of the device in reconstruction and fixation of small foot bones
You may also be interested in...
Pharmaceutical companies struggling to keep up with coronavirus-related supply chain havoc asked to keep the US regulator informed as situation unfolds.
Pfizer's third US FDA warning letter since 2018 goes to injectables site in Vizag, India; tells the company to up its game in sterility testing and in the microbiology lab.
Gilead lands on Second Genome as its first partner to apply microbiome analysis to pipeline assets to look for biomarkers. Companies also team up on GI drug discovery.